3D MEDICINES (01244): Liang Jingjing has been appointed as the agent for legal process documents.
Siqudi Pharmaceutical Co., Ltd. (01244) announced that Ms. Liang Jingjing has been appointed to replace Ms. Li Jingyi as the agent to receive legal proceedings and notices on behalf of the company in Hong Kong, effective from August 4, 2026.
3D MEDICINES (01244) announced that Ms. Liang Jingjing has been appointed to replace Ms. Li Jingyi as the agent for the company to receive legal documents and notifications in Hong Kong, effective from August 4, 2026.
Related Articles
US Stock Market Move | Zebra Technologies Corporation Class A (ZBRA.US) surged over 19% as Q2 earnings exceeded expectations and the full-year guidance was raised.
KINETIC DEV(01277): The Makhado project has officially started production.
TONTINE WINES (00389) rejects the proposal for the major shareholder Wang Hexin to subscribe for new shares.
US Stock Market Move | Zebra Technologies Corporation Class A (ZBRA.US) surged over 19% as Q2 earnings exceeded expectations and the full-year guidance was raised.
KINETIC DEV(01277): The Makhado project has officially started production.
TONTINE WINES (00389) rejects the proposal for the major shareholder Wang Hexin to subscribe for new shares.
RECOMMEND
